BiotechTube

Gonal-f® + Pergoveris® + Pergoveris® + Recombinant human chorionic gonadotropin (r-hCG)

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Assisted Reproductive Techniques

Conditions

Assisted Reproductive Techniques, Reproductive Technology, Assisted

Trial Timeline

May 31, 2011 → Oct 31, 2012

NCT ID
NCT01297465

About Gonal-f® + Pergoveris® + Pergoveris® + Recombinant human chorionic gonadotropin (r-hCG)

Gonal-f® + Pergoveris® + Pergoveris® + Recombinant human chorionic gonadotropin (r-hCG) is a phase 3 stage product being developed by Merck for Assisted Reproductive Techniques. The current trial status is completed. This product is registered under clinical trial identifier NCT01297465. Target conditions include Assisted Reproductive Techniques, Reproductive Technology, Assisted.

What happened to similar drugs?

0 of 1 similar drugs in Assisted Reproductive Techniques were approved

Approved (0) Terminated (1) Active (0)
❌Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH) + r-hFSHMerckPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01297465Phase 3Completed

Competing Products

4 competing products in Assisted Reproductive Techniques

See all competitors
ProductCompanyStageHype Score
SHR7280 tablets + SHR7280 dry suspensionJiangsu Hengrui MedicinePhase 1
29
[14C]SHR7280Jiangsu Hengrui MedicinePhase 1
29
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
35
Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH) + r-hFSHMerckPhase 3
32